Global Artificial Pancreas Device Market Size
Forecasted to reach US$ 1361.5 million by 2034, the Artificial Pancreas Device Systems Market was valued at US$ 278.1 million in 2024 and is expected to grow at a CAGR of 17.40%.
The organ in the body that makes and secretes digestive juices is the pancreas. The small intestine, spleen, stomach, liver, and gall bladder encircle the pancreases, which produce digestive enzymes such as trypsin and chymotrypsin. The endocrine function of the pancreas is replaced by an artificial pancreas system that tracks blood glucose levels. It automatically adjusts the insulin supply in addition to monitoring the body's glucose level to reduce elevated blood glucose levels.
The primary drivers of the market's expansion are the growing government initiatives in clinical research, the growing demand for home care setup devices, and remote monitoring applications. The market for artificial pancreas devices has grown as a result of increased research and development efforts as well as growing demand for automated systems for glycemic control.